Dendritic cell vaccine therapy in breast cancer patients

10^th Global Annual Oncologists Meeting

July 11-13, 2016 Cologne, Germany

Yathish Kumar

Karnataka cancer hopsital & research centre, India

Scientific Tracks Abstracts: J Cancer Sci Ther

Abstract :

Breast cancer continues to be a leading cause of death in Indian cancer patients. 20-30% of breast cancers relapse, despite of multi modality treatments for the same. Although considered immunologically silent, breast cancer is recently treated or being tried to be treated with immunologiocal treatment modalities. One such exciting modality is treatment with â�?�?dendritic cell vaccineâ�?. As experimental therapy, dendritic cell therapy offers hope to those who have no options left in the course of their treatment and also to those few who want to avoid traditional chemotherapy and targeted therapy either in combination or alone. Dendritic cell vaccine is prepared by autologous method i.e from the patient herself and is sensitised with various antigens including tumor cell lysates, interleukins, cytokines and other adjuvants. We present our experience in producing the dendritic cells and treating breast cancer patients at our centre in Bangalore, India.We have treated 14 breast cancer patinets at various stages. Our method of harvesting and preparing dendritic cell from patients blood and activating the preparation is unique. We are currently offering these vaccine under a investigator driven protocol.

Biography :

Yathish Kumar has completed his Master’s in Surgical Oncology with keen interest in molecular basis of cancer etiology and treatement. He has established a dedicated cancer treatment unit at Bangalore. He trains young surgeons to Surgical Oncologits. He has keen interest in developing new, innovative and evidence based treatment protocols in cancer treatment especially by molecular/immunological methods.

Email: dryathish@hotmail.com